COMMUNIQUÉS West-GlobeNewswire

FibroGen Presents Results from Two Phase 3 Studies of Roxadustat for the Treatment of Anemia Associated with Chronic Kidney Disease Conducted in China at American Society of Nephrology Kidney Week 2018 Annual Meeting
26/10/2018
SAN FRANCISCO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, and FibroGen China Medical [...]
Bionano Genomics to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
26/10/2018
Call Scheduled for Wednesday, November 7 th @ 4:30pm Eastern Time SAN DIEGO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets [...]
Adherium Announces Q1 Fiscal Year 2019 Investor Conference Call
26/10/2018
SAN MATEO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, will host a conference call on Tuesday, October 30, 2018 at 6. [...]
TOMI Environmental Solutions, Inc. Exhibits SteraMist™ Disinfection Products at the American Association for Laboratory Animal Science (AALAS) Annual Meeting
25/10/2018
BEVERLY HILLS, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, including [...]
MannKind Corporation to Hold 2018 Third Quarter Financial Results Conference Call on November 1, 2018
25/10/2018
WESTLAKE VILLAGE, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will host a conference call to discuss the 2018 third quarter and year-to-date financial results and other corporate [...]
Adaptimmune to Report Third Quarter 2018 Financial Results and Business Update on Tuesday, November 6, 2018
25/10/2018
PHILADELPHIA and OXFORD, United Kingdom, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the Third Quarter [...]
Spring Bank Pharmaceuticals Reports Third Quarter Financial Results
25/10/2018
HOPKINTON, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Histogenics Corporation to Report Third Quarter 2018 Financial Results on November 8, 2018
25/10/2018
WALTHAM, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, announced [...]
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
25/10/2018
MENLO PARK, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report its third quarter 2018 financial results and provide a corporate update on November 1 [...]
HTG Molecular Diagnostics to Announce Third Quarter and Nine Months Ended September 30, 2018 Financial Results and Host Conference Call on Thursday, November 8
25/10/2018
TUCSON, Ariz., Oct. 25, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced that it will [...]
MRI Interventions Congratulates Axovant on First Patient Dosing in New Gene Therapy Clinical Study for Patients with Parkinson’s Disease
25/10/2018
Initial Data Expected in First Half of 2019 IRVINE, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Axovant Sciences Ltd. on the dosing of its first patient in a clinical study of [...]
Candesant Biomedical Announces Positive Safety and Efficacy Data for Treatment of Hyperhidrosis
25/10/2018
Novel treatment offers hope for people who suffer from excessive sweating SAN FRANCISCO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Candesant Biomedical (“Candesant”), a company dedicated to alleviating the suffering of those [...]
IRIDEX to Participate in Upcoming Investor Conferences
25/10/2018
MOUNTAIN VIEW, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in upcoming investor conferences. IRIDEX’s management is scheduled to present [...]
Harvard Bioscience Reports Third Quarter 2018 Financial Results
25/10/2018
-Reports GAAP and adjusted non-GAAP revenue of $28.6 million and $28.7 million, respectively, an increase of 53% and 15%, respectively- HOLLISTON, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. ( [...]
RxBenefit Clarity™ Available Soon to Allscripts Users
25/10/2018
New Offering from CoverMyMeds and RelayHealth Pharmacy Solutions Will Provide Accurate Prescription Price Information, Prescribing Decision Support and Streamlined Medication Access CHICAGO, Oct. 25, 2018 (GLOBE [...]
Inspire Medical Systems, Inc. to Present at the Stifel 2018 Healthcare Conference
25/10/2018
MINNEAPOLIS, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Merit Medical Reports Earnings for Third Quarter of 2018
25/10/2018
Q3 2018 worldwide revenue of $221.7 million ($223.1 million on a comparable, constant currency* basis), up 23.6% as reported (up 24.4% on a comparable, constant currency* basis) over Q3 2017 Q3 2018 core revenue* up 14. [...]
Retrophin Announces Publication of Phase 2 DUET Study of Sparsentan for the Treatment of Focal Segmental Glomerulosclerosis in the Journal of the American Society of Nephrology
25/10/2018
DUET publication highlighted during Best of ASN Journals session at ASN Kidney Week 2018 SAN DIEGO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that the Journal of the American [...]
Cerner Reports Third Quarter 2018 Results
25/10/2018
KANSAS CITY, Mo., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced results for the 2018 third quarter that ended September 29, 2018. Bookings in the third quarter of 2018 were $1.588 [...]

Pages